DBT

DBT (DBT) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 13,000 VND, little changed on the session, giving a market capitalization of 274.6 billion VND.

On valuation, DBT trades at a price-to-earnings ratio of 10.0 and a price-to-book of 1.0. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 9.8% points to modest profitability relative to the company's equity base, below the sector average of 11.5%. Trailing earnings per share stand at 1,325 VND.

Aveluro tracks 3 news items mentioning DBT. The most recent catalyst was a leadership change event — "DBT appoints Nam A Bank chairman's daughter as deputy CEO in board reshuffle". Aveluro's composite model rates DBT 6.7/10 (Bullish), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Recent developments around DBT include 3 notable classified events. On Aug 03, 2026, a leadership change was reported: Ben Tre Pharmaceutical (DBT) elected a new five-member board at an extraordinary shareholder meeting, appointing Tran Dinh Van as chairman and Tran Ngo Minh Anh, daughter of Nam A Bank chairman Tran Ngo Phuc Vu, as deputy general director. On Aug 03, 2026, a leadership change was reported: DBT has appointed Tran Ngo Minh Anh, daughter of Nam A Bank chairman Tran Ngo Phuc Vu, as Deputy General Director, alongside a new five-member board. A recent a leadership change was reported: Ben Tre Pharmaceutical (DBT) held an extraordinary shareholder meeting, replacing five board members and appointing a new chairman and deputy general director, including Tran Ngo Minh Anh, daughter of Nam A Bank's chairman.

Recent coverage shows a mixed sentiment balance across events.